Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNeoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pancreatic ductal adenocarcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, small cell lung carcinoma, triple-negative breast carcinomaActive, not recruitingPhase 22026-09-25NCT02498613

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AstraZeneca806
National Cancer Institute (NCI)3015

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BCCA-Vancouver Cancer CentreVancouverCanada35
Dana-Farber Cancer InstituteBostonUnited States626
Moffitt Cancer CenterTampaUnited States523
Moffitt Cancer Center-International PlazaTampaUnited States67
Smilow Cancer Center/Yale-New Haven HospitalNew HavenUnited States91
UC San Diego Medical Center - HillcrestSan DiegoUnited States57
UC San Diego Moores Cancer CenterLa JollaUnited States199
UCSF Medical Center-Mount ZionSan FranciscoUnited States26
University Health Network-Princess Margaret HospitalTorontoCanada88
University of California Davis Comprehensive Cancer CenterSacramentoUnited States299
UT MD Anderson Cancer CenterHoustonUnited States204
Vanderbilt University/Ingram Cancer CenterNashvilleUnited States259
VCU Massey Comprehensive Cancer CenterRichmondUnited States273
Wayne State University/Karmanos Cancer InstituteDetroitUnited States196
Weisberg Cancer Treatment CenterFarmington HillsUnited States135
Yale UniversityNew HavenUnited States352